Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells | |
Wang, Yunshan; Wei, Junmin; Li, Li; Fan, Cong; Sun, Ying | |
刊名 | ONCOLOGY RESEARCH
![]() |
2015 | |
卷号 | 22期号:4页码:193-201 |
关键词 | Metformin Everolimus Breast cancer Adenosine 5 '-monophosphate-activated protein kinase (AMPK) Mammalian target of rapamycin (mTOR) |
DOI | 10.3727/096504015X14348950540999 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4792764 |
专题 | 山东大学 |
作者单位 | 1.Shandong Univ, Sch Med, Minist Educ, Dept Human Anat, Jinan 250012, Shandong, Peoples R China. 2.Shandong Univ, Sch M |
推荐引用方式 GB/T 7714 | Wang, Yunshan,Wei, Junmin,Li, Li,et al. Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells[J]. ONCOLOGY RESEARCH,2015,22(4):193-201. |
APA | Wang, Yunshan,Wei, Junmin,Li, Li,Fan, Cong,&Sun, Ying.(2015).Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells.ONCOLOGY RESEARCH,22(4),193-201. |
MLA | Wang, Yunshan,et al."Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells".ONCOLOGY RESEARCH 22.4(2015):193-201. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论